Las Vegas, NV -- (SBWIRE) -- 01/04/2013 -- Cellceutix Corp (OTC:CTIX) is emerging as one of the most promising stocks in recent history. Cellceutix Corp is a major brand in the drug-resistant cancer market niche and is sitting on a potentially, multi-billion dollar offerings. Recently, the stock has reached a high of $2.50 per share. After rising, the stock did drop significantly and analysts are pondering whether it can repeat its previous surge.
Cellceutix Corp (OTC:CTIX) recently revealed a bit about its plan for 2013. Their flagship drug—Kevetrin(TM) is among the most talked about anti-cancer drugs. It can address a wide range of cancers. This year, the Company seeks to make leading establishments notice and acknowledge the potential of this drug. The Drug made significant progress in 2012 and is poised to engage more attention in 2013.
Cellceutix Corporation CTIX is primarily a biopharmaceutical company that is focused on discovering and developing drug therapies for hard-to-treat conditions like drug-resistant cancers and autoimmune disorders. Based in Beverly, Massachusetts, the Company has a history of creating globally-acknowledged cancer drugs like Gemzar and Alimta.
To find out what OTCMAGIC projects for CTIX, both short term and long term, please go here: CTIX
OTCMAGIC spends the entire day researching markets for the next, Penny Stock Winner! The number of Investors trusting OTCMAGIC for getting the latest and accurate commentary for all the hot stocks has risen consistently over the years. To view what OTCMAGIC can do for your Penny Stocks portfolio, click on OTCMAGIC right now! With the number of monthly visitors currently pegged at 30,000 and growing continuously, OTCMAGIC is the unargued specialist in Penny Stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)